Growth for Growth's Sake (The Cancer Metaphor)

When an organization pursues growth as an end rather than a means, it metastasizes—expanding into areas where it has no competitive advantage, diluting culture, and consuming resources that should fund quality or sustainability. The biological analogy is precise: cancer cells grow without regard for the organism's health, and growth-obsessed organizations similarly cannibalize their own foundations. The pattern: (1) growth is initially a byproduct of value creation, (2) growth becomes the primary metric, (3) growth requires entering new markets or segments where the org has no edge, (4) quality/culture dilutes to support growth, (5) the foundation weakens while the superstructure expands, (6) collapse. WeWork expanding from coworking to co-living, a wave pool company, and an elementary school. GE under Welch and Immelt acquiring everything in sight until the portfolio was incoherent. The tell: when the growth narrative requires increasingly creative definitions of the 'addressable market.'

When to use it

When evaluating growth strategies or acquisitions. When the company narrative is increasingly about market size rather than product quality. When growth rate is celebrated despite declining margins, retention, or quality metrics. During strategic planning.

How it can help

Provides a framework for distinguishing healthy growth (driven by genuine value creation and competitive advantage) from cancerous growth (driven by metric obsession and market narrative). The test: for each growth initiative, ask 'Would we enter this market if we weren't under pressure to grow?' and 'Do we have a genuine right to win here?' Prevention requires defining growth constraints—maximum rate of new market entry, maximum culture dilution tolerance, minimum quality thresholds that override growth targets. Build investor communications around unit economics and quality metrics, not just top-line growth.